Global Exosomes Market Size, Share, Trends, And Forecast, 2026-2033 Market To Reach $1.2 Billion At 23.0% CAGR As Liquid Biopsy And Drug Delivery Opportunities Expand

(MENAFN- GlobeNewsWire - Nasdaq) Explore exosome market opportunities across products, workflows, disease applications, end users and regions, backed by detailed analysis of emerging industry trends.

Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Exosomes Market Size, Share & Trends Analysis Report by Product & Service, Workflow, Application, End Use, Region, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global exosomes market was valued at USD 229.3 million in 2025 and is projected to reach USD 1.2 billion by 2033. The market is expected to grow at a compound annual growth rate of 23.0% between 2026 and 2033, reflecting increasing investment in exosome research, diagnostic development, biomarker discovery, and therapeutic applications.

Market expansion is supported by continued advances in exosome isolation, characterization, and downstream analysis. Pharmaceutical and biotechnology companies, hospitals and diagnostics centers, and academic and research institutes are increasingly incorporating exosome technologies into research and development programs. Demand for specialized kits, reagents, instruments, and services is also contributing to the commercial growth of the global exosomes market.

Exosome applications span cancer, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and other clinical research areas. Cancer represents a key field of investigation due to the growing use of extracellular vesicle analysis in biomarker research, disease monitoring, and the development of potential diagnostic and therapeutic approaches. Research involving neurological, cardiovascular, and infectious conditions is also broadening the market's long-term commercial potential.

Global Exosomes Market Report Segmentation

The report forecasts revenue growth at the global, regional, and country levels and analyzes current exosomes market trends across each sub-segment from 2021 to 2033. The study segments the market by product & service, workflow, application, end use, and region, providing a structured assessment of growth opportunities throughout the industry.

Product & Service Outlook (Revenue, USD Million, 2021-2033)

• Kits & Reagents
• Instruments
• Services

The product and service analysis covers the laboratory consumables, analytical platforms, and specialized support required for exosome research. Kits & Reagents support routine isolation and analysis, while instruments enable processing and characterization. Services provide external expertise and operational capacity for organizations seeking dedicated exosome research capabilities.

Workflow Outlook (Revenue, USD Million, 2021-2033)

• Isolation Methods
  • Ultracentrifugation
  • Immunocapture on beads
  • Precipitation
  • Filtration
  • Others
• Downstream Analysis
  • Cell surface marker analysis using flow cytometry
  • Protein analysis using blotting & ELISA
  • RNA analysis with NGS & PCR
  • Proteomic analysis using mass spectroscopy
  • Others

Workflow segmentation examines both isolation methods and downstream analytical techniques. This coverage enables assessment of established laboratory processes alongside emerging technologies used to evaluate cell surface markers, proteins, RNA, and proteomic profiles.

Application Outlook (Revenue, USD Million, 2021-2033)

• Cancer
• Neurodegenerative diseases
• Cardiovascular diseases
• Infectious diseases
• Others

End Use Outlook (Revenue, USD Million, 2021-2033)

• Pharmaceutical & biotechnology companies
• Hospitals & diagnostics centers
• Academic & research institutes

Regional Outlook (Revenue, USD Million, 2021-2033)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Singapore
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

The regional analysis evaluates exosomes market revenue across major developed and emerging economies. Coverage of North America, Europe, Asia Pacific, Latin America, and MEA provides insight into geographic adoption patterns, research activity, commercial development, and country-level opportunities through 2033.

Key Attributes:

Report Attribute	Details
No. of Pages	120
Forecast Period	2025 - 2033
Estimated Market Value (USD) in 2025	$229.3 Million
Forecasted Market Value (USD) by 2033	$1200 Million
Compound Annual Growth Rate	23.0%
Regions Covered	Global

Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Workflow Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information and Data Analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Total Market: CAGR Calculation
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Exosomes Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Advancements in Liquid Biopsy and Non-Invasive Diagnostics
3.2.1.2. Growing Demand for Advanced Drug Delivery and Cancer Diagnostics
3.2.1.3. Growth in government and non-government initiatives for exosome research
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations pertaining to approval
3.2.2.2. Challenges associated with the implementation of exosome-based therapies
3.2.3. Market Challenges Analysis
3.2.4. Market Opportunity Analysis
3.3. Case Study Insights
3.4. Exosomes Market Analysis Tools
3.4.1. Industry Analysis - Porter's Five Forces Analysis
3.4.2. PESTEL Analysis
Chapter 4. Exosomes Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Exosomes Market Product & Service Movement Analysis
4.3. Global Exosomes Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Kits & reagents
4.4.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Instruments
4.5.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Services
4.6.1. Services market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Exosomes Market: Workflow Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Exosomes Market Workflow Movement Analysis
5.3. Global Exosomes Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
5.4. Isolation Methods
5.4.1. Isolation methods market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Ultracentrifugation
5.4.2.1. Ultracentrifugation market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3. Immunocapture on beads
5.4.3.1. Immunocapture on beads market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4. Precipitation
5.4.4.1. Precipitation market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5. Filtration
5.4.5.1. Filtration market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6. Others
5.4.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Downstream Analysis
5.5.1. Downstream analysis market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. Cell surface marker analysis using flow cytometry
5.5.2.1. Cell surface marker analysis using flow cytometry market estimates and forecasts 2021 to 2033 (USD Million)
5.5.3. Protein Analysis using blotting & ELISA
5.5.3.1. Protein Analysis using blotting & ELISA market estimates and forecasts 2021 to 2033 (USD Million)
5.5.4. RNA analysis with NGS & PCR
5.5.4.1. RNA analysis with NGS & PCR market estimates and forecasts 2021 to 2033 (USD Million)
5.5.5. Proteomic analysis using mass spectroscopy
5.5.5.1. Proteomic analysis using mass spectroscopy market estimates and forecasts 2021 to 2033 (USD Million)
5.5.6. Others
5.5.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Exosomes Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Exosomes Market Application Movement Analysis
6.3. Global Exosomes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Cancer
6.4.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Neurodegenerative Diseases
6.5.1. Neurodegenerative diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Cardiovascular Diseases
6.6.1. Cardiovascular diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Infectious Diseases
6.7.1. Infectious diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Others
6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Exosomes Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Exosomes Market End Use Movement Analysis
7.3. Global Exosomes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Hospitals & Diagnostics Centers
7.5.1. Hospitals & diagnostics centers market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Academic & Research Institutes
7.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Exosomes Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033
8.4. North America
8.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. U.S.: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Canada: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.4.4. Mexico: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Europe
8.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
8.5.2. UK: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.5.3. Germany: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.5.4. France: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.5.5. Italy: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.5.6. Spain: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.5.7. Norway: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.5.8. Sweden: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.5.9. Denmark: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
8.6.2. Japan: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.6.3. China: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.6.4. India: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.6.5. Australia: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.6.6. South Korea: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.6.7. Thailand: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.6.8. Singapore: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Latin America
8.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
8.7.2. Brazil: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.7.3. Argentina: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.8. MEA
8.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
8.8.2. South Africa: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.8.3. Saudi Arabia: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.8.4. UAE: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
8.8.5. Kuwait: Key country dynamics; competitive scenario; regulatory framework; market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles/Listing
9.4.1. Bio-Techne Corporation: Company overview; financial performance; product benchmarking; strategic initiatives
9.4.2. Danaher Corporation: Company overview; financial performance; product benchmarking; strategic initiatives
9.4.3. Hologic Inc.: Company overview; financial performance; product benchmarking; strategic initiatives
9.4.4. Fujifilm Holdings Corporation: Company overview; financial performance; product benchmarking; strategic initiatives
9.4.5. Lonza: Company overview; financial performance; product benchmarking; strategic initiatives
9.4.6. Miltenyi Biotec: Company overview; financial performance; product benchmarking; strategic initiatives
9.4.7. QIAGEN: Company overview; financial performance; product benchmarking; strategic initiatives
9.4.8. Thermo Fisher Scientific, Inc.: Company overview; financial performance; product benchmarking; strategic initiatives
9.4.9. Abcam Plc: Company overview; financial performance; product benchmarking; strategic initiatives
9.4.10. RoosterBio, Inc.: Company overview; financial performance; product benchmarking; strategic initiatives
List of Tables [128]
List of Figures [98]
Companies Featured

• Danaher Corporation
• Hologic Inc.
• Fujifilm Holdings Corporation
• Lonza
• Miltenyi Biotec
• Bio-Techne Corporation
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Abcam plc
• RoosterBio, Inc.

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN28092026004107003653ID1111724691